MitoChem Therapeutics

0 followers


With funding from Foundation Fighting Blindness and the NIH the company synthesized compounds that demonstrate promise for treating vision loss from retinitis pigmentosa, age-related macular degeneration and glaucoma.

Industries

Employees

11-50

Links

Org chart

Michael Voevodsky
President & CEO

Michael Voevodsky

Collapse
Bärbel Rohrer
Co-Founder & CSO
Craig Beeson
Co-founder
Dan Adams
Director